Apogee Therapeutics, Inc. APGE Investment Income, Amortization of Discount
Investment Income, Amortization of Discount at other companies
Other financials
Where this comes from
Reported directly by Apogee Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeAmortizationOfDiscount.
The official record: Apogee Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Apogee Therapeutics, Inc.'s investment income, amortization of discount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Apogee Therapeutics, Inc.'s investment income, amortization of discount?
- Apogee Therapeutics, Inc. (APGE) reported investment income, amortization of discount of $1.55M in Q1 2026.
- How has Apogee Therapeutics, Inc.'s investment income, amortization of discount changed year-over-year?
- Apogee Therapeutics, Inc.'s investment income, amortization of discount decreased by 34.9% year-over-year, from $2.38M to $1.55M.
- What does investment income, amortization of discount mean?
- This represents the non-cash adjustment to net income related to the accretion of discounts on held-to-maturity or available-for-sale investment securities. It reflects the gradual recognition of interest income over the life of the investment, which does not impact operating cash flow. Investors monitor this to distinguish between actual cash interest received and accounting-based income accruals.